Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Retraction: characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma.
Stevenson M, Mostertz W, Acharya CR, Kim W, Walters K, Barry W, Higgins K, Tuchman SA, Crawford J, Vlahovic G, Ready N, Onaitis M, Potti A. Stevenson M, et al. Clin Cancer Res. 2012 Mar 15;18(6):1818. doi: 10.1158/1078-0432.CCR-12-0337. Epub 2012 Feb 21. Clin Cancer Res. 2012. PMID: 22355011 No abstract available.
Immunotherapy approaches in the treatment of malignant brain tumors.
Dunn-Pirio AM, Vlahovic G. Dunn-Pirio AM, et al. Among authors: Vlahovic G. Cancer. 2017 Mar 1;123(5):734-750. doi: 10.1002/cncr.30371. Epub 2016 Nov 22. Cancer. 2017. PMID: 27875627 Free article. Review.
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.
Reap EA, Suryadevara CM, Batich KA, Sanchez-Perez L, Archer GE, Schmittling RJ, Norberg PK, Herndon JE 2nd, Healy P, Congdon KL, Gedeon PC, Campbell OC, Swartz AM, Riccione KA, Yi JS, Hossain-Ibrahim MK, Saraswathula A, Nair SK, Dunn-Pirio AM, Broome TM, Weinhold KJ, Desjardins A, Vlahovic G, McLendon RE, Friedman AH, Friedman HS, Bigner DD, Fecci PE, Mitchell DA, Sampson JH. Reap EA, et al. Among authors: Vlahovic G. Cancer Res. 2018 Jan 1;78(1):256-264. doi: 10.1158/0008-5472.CAN-17-0469. Epub 2017 Nov 1. Cancer Res. 2018. PMID: 29093005 Free PMC article. Clinical Trial.
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.
Batich KA, Reap EA, Archer GE, Sanchez-Perez L, Nair SK, Schmittling RJ, Norberg P, Xie W, Herndon JE 2nd, Healy P, McLendon RE, Friedman AH, Friedman HS, Bigner D, Vlahovic G, Mitchell DA, Sampson JH. Batich KA, et al. Among authors: Vlahovic G. Clin Cancer Res. 2017 Apr 15;23(8):1898-1909. doi: 10.1158/1078-0432.CCR-16-2057. Clin Cancer Res. 2017. PMID: 28411277 Free PMC article. Clinical Trial.
Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation.
Vlahovic G, Rabbani ZN, Herndon JE 2nd, Dewhirst MW, Vujaskovic Z. Vlahovic G, et al. Br J Cancer. 2006 Oct 23;95(8):1013-9. doi: 10.1038/sj.bjc.6603366. Epub 2006 Sep 26. Br J Cancer. 2006. PMID: 17003785 Free PMC article.
Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts.
Vlahovic G, Ponce AM, Rabbani Z, Salahuddin FK, Zgonjanin L, Spasojevic I, Vujaskovic Z, Dewhirst MW. Vlahovic G, et al. Br J Cancer. 2007 Sep 17;97(6):735-40. doi: 10.1038/sj.bjc.6603941. Epub 2007 Aug 21. Br J Cancer. 2007. PMID: 17712313 Free PMC article.
Hypoxia, angiogenesis, and lung cancer.
Goudar RK, Vlahovic G. Goudar RK, et al. Curr Oncol Rep. 2008 Jul;10(4):277-82. doi: 10.1007/s11912-008-0043-6. Curr Oncol Rep. 2008. PMID: 18778551 Review.
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial.
O'Reilly EM, Oh DY, Dhani N, Renouf DJ, Lee MA, Sun W, Fisher G, Hezel A, Chang SC, Vlahovic G, Takahashi O, Yang Y, Fitts D, Philip PA. O'Reilly EM, et al. Among authors: Vlahovic G. JAMA Oncol. 2019 Jul 18;5(10):1431-8. doi: 10.1001/jamaoncol.2019.1588. Online ahead of print. JAMA Oncol. 2019. PMID: 31318392
36 results
Jump to page